Attovia Therapeutics, Inc. (ATTO) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−19.8x

Market Cap

$1.17B

MomentumView details →

1D Return

+5.58%

YTD Return

—

RSI (14)

66.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−19.8x

Market Cap

$1.17B

RSI (14)

66.9

MomentumView details →

1D Return

+5.58%

YTD Return

—

ProfitabilityView details →

Gross Margin

40.44%

Net Margin

−4490.89%

EBITDA Margin

−4915.19%

ROE (TTM)

−53.76%

ROA (TTM)

−47.24%

Asset Turnover

0.01x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

−35.24%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−$4.88

EPS Surprise

−655.53%

Beats (12Q)

0/12

Next Q EPS Est

−$0.56

Avg Surprise (4Q)

−655.53%

Rev Surprise

42.11%

Capital & dividendView details →

Debt/Equity

0.04x

Current Ratio

9.39x

Quick Ratio

9.39x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Latest newsMore news →

No recent news for ATTO.

Similar companies

Kura Oncology, Inc.KURA Sana Biotechnology, Inc.SANA Monte Rosa Therapeutics, Inc.GLUE Inventiva S.A.IVA Corvus Pharmaceuticals, Inc.CRVS Savara Inc.SVRA Find similar companies →

Latest newsMore news →

No recent news for ATTO.